Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s12185-022-03398-6
Published Online: 2022-06-23
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Xing-yu
Li, Jing-jing
Lu, Pei-hua
Liu, Kai-yan http://orcid.org/0000-0002-6331-7369
Text and Data Mining valid from 2022-06-23
Version of Record valid from 2022-06-23
Article History
Received: 11 April 2022
Revised: 30 May 2022
Accepted: 30 May 2022
First Online: 23 June 2022
Declarations
:
: All the authors declare no conflict of interest.